Study of the absorption, metabolism, and excretion of (14C)-ramelteon (TAK-375).

被引：0
|
作者：
Stevenson, S
Cornelissen, K
Clarke, E
Hibberd, M
机构：
[1] Covance Labs Ltd, Covance CRU, Leeds, W Yorkshire, England
[2] Takeda Europe R&D Ctr Ltd, London, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P22 / P22
页数：1
相关论文
共 50 条
  • [31] EXCRETION AND METABOLISM OF [14C]-PYRIDOSTIGMINE IN RAT
    BIRTLEY, RDN
    ROBERTS, JB
    THOMAS, BH
    WILSON, A
    BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (02): : 393 - &
  • [32] Effect of age and gender on the pharmacokinetics of ramelteon (TAK-375), a novel selective ML-1 receptor agonist.
    Greenblatt, DJ
    Harmatz, JS
    Karim, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S125 - S125
  • [33] Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats
    Hirai, K
    Kita, M
    Ohta, H
    Nishikawa, H
    Fujiwara, Y
    Ohkawa, S
    Miyamoto, M
    JOURNAL OF BIOLOGICAL RHYTHMS, 2005, 20 (01) : 27 - 37
  • [34] Absorption, distribution, metabolism, and excretion of [1-14C]-perfluorohexanoate ([14C]-PFHx) in rats and mice
    Gannon, Shawn A.
    Johnson, Terry
    Nabb, Diane L.
    Serex, Tessa L.
    Buck, Robert C.
    Loveless, Scott E.
    TOXICOLOGY, 2011, 283 (01) : 55 - 62
  • [35] Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
    Yihua E. Ye
    Caroline N. Woodward
    Narayana I. Narasimhan
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 507 - 518
  • [36] Absorption, metabolism and excretion of [14C]-ABT-510 in healthy subjects.
    Achari, R
    Aoyama, R
    Knight, R
    Humerickhouse, R
    O'Dea, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1074 - 1074
  • [37] Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
    Ye, Yihua E.
    Woodward, Caroline N.
    Narasimhan, Narayana I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 507 - 518
  • [38] ABSORPTION DISTRIBUTION METABOLISM AND EXCRETION OF ORAL [14C]-IBREXAFUNGERP IN HEALTHY MALE SUBJECTS
    Azie, N.
    Angulo, D.
    Evans, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [39] Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers
    Stangier, J
    Schmidt, J
    Türck, D
    Switek, H
    Verhagen, A
    Peeters, PAM
    van Marle, SP
    Tamminga, WJ
    Sollie, FAE
    Jonkman, JHG
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1312 - 1322
  • [40] STUDIES ON ABSORPTION AND EXCRETION OF [14C]-BETHANIDINE IN MAN
    DOYLE, AE
    MORLEY, A
    BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1965, 24 (03): : 701 - &
12345